Synthetic organic

InformationETC-1002 ETC-1002 (Bempedoic acid, ESP-55016),also known as Bempedoic acid, is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing

InformationETC-1002 ETC-1002 (Bempedoic acid, ESP-55016),also known as Bempedoic acid, is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing

InformationETC-159 ETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.TargetsPorcnIn vitroETC-159 treatment causes decreased abundance of

InformationETC-159 ETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.TargetsPorcnIn vitroETC-159 treatment causes decreased abundance of

InformationETC-159 ETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.TargetsPorcnIn vitroETC-159 treatment causes decreased abundance of

InformationETC-159 ETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.TargetsPorcnIn vitroETC-159 treatment causes decreased abundance of

InformationETC-159 ETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.TargetsPorcnIn vitroETC-159 treatment causes decreased abundance of

InformationETC-159 ETC-159 (ETC-1922159) is an orally available, potent porcupine inhibitor with an IC50 of 2.9 nM for inhibiting β-catenin reporter activity in STF3A cells.TargetsPorcnIn vitroETC-159 treatment causes decreased abundance of

ETC-206 (AUM 001).

ETC-206 (AUM 001).

ETC-206 (AUM 001).

ETC-206 (AUM 001).